Home Icon

Loading, Please Wait...

Immunoglobulins Market to Touch US$ 20,757.1 Mn by 2026, Advancements in Research and Development of Plasma Synthesis to Boost Prospects - TMR

1142 Days ago

Immunoglobulins Market: Awareness of Effective Immunoglobulins Products to Boost the Market Growth

Albany, NY, April 11, 2019 (GLOBE NEWSWIRE) -- Transparency Market Research (TMR) points entry of new players in the global immunoglobulins market. This is due to a significant boost in number of FDA approvals for immunoglobulins drugs and vaccinations. Key players are ramping their investments in research and development of cost effective and sensitive immunoglobulin therapies with less side effects. This is expected to offer new opportunities to the immunoglobulins market in the years ahead.

The global immunoglobulin market is consolidated with limited number of players. Key players have a high dominance over the global revenue share in the market. Mergers and acquisitions, business expansions and collaborations are few common growth strategies that vendors in the immunoglobiluns market have resorted to, to expand their global outreach.  Some of the key players operating in the global immunoglobiluns market Baxter International Inc., Biotest AG, Octapharma AG, Grifols SA, LFB Biotechnologies, CSL Behring, Kedrion Biopharma, BDI Pharma Inc., and China Biologics Products Inc.

Request to View Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=52353

According to a new market study by TMR, the global immunoglobulins market is projected to reach a valuation of US$20,757.1 mn by 2026. The market is likely to expanding at a CAGR of 7.2% from 2017 to 2026. The analysts noted the global immunoglobulins market at a valuation of US$10,980 mn in 2017.

Geographically, North America is anticipated to dominate the global immunoglobulin market throughout the forecast period. This is mainly due to the presence of several prominent players and growth in prevalence of autoimmune disorders in the region. Based on route of administration, the intravenous segment is projected to hold a majority of share in the market owing to increased usage of intravenous antibody in a wide range of immunology applications.

Request PDF Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=52353

High Costs of Immunoglobulins Due to Heft Government Tax to Impede Growth

The global immunoglobulins market is expected to grow at a significant pace during the forecast period. Increase in consumption of saturated fats salt, & sugars, high alcohol consumptions and less physical activities have increased prevalence of autoimmune diseases. The growing prevalence of autoimmune diseases across the globe is a strong factor anticipated to swell demand for immunoglobulins in the market. Immunoglobulins are antibodies used to treat patients with immune deficiencies syndrome. They are primarily obtained from healthy blood plasma through fractionation processes. An increase in collection of plasma across the globe is another factor expected to fuel the immunoglobulins market.

On the flipside, hefty tax on import of several immunoglobulin products by governments and strict government guidelines related to the use of immunoglobulin products could hamper the growth of the global immunoglobulins market. Apart from this, several side effects of immunoglobulins on patients such as allergic reactions, kidney problems, or blood clots are imbibing a sense of reluctance among patients regarding use of immonoglobulins. This may impede growth of the global immunoglobulin market on a global scale.

Request For Discount On This Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=52353

Adequate Results of Intravenous Therapeutics on Patients to Increase Adoption

Nevertheless, increasing healthcare expenditure and technological advancements in research and development of immunoglobulins is expected to offer lucrative avenues for the growth of the global immunoglobulins market. The demand for Intravenous therapeutics for the treatment of acquired and primary immunodeficiency diseases is increasing. Moreover, rising prevalence of lifestyle associated disorders and antibody deficiency disorders are the factors expected to drive the market’s growth.

More Trending Reports by Transparency Market Research:

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.


Mr. Rohit Bhisey
Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany, NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Research Blog: http://theglobalhealthnews.com/

We Are Diffrent
Is your business listed correctly on America’s largest city directory network of 1,000 portals? Find your City Portal